Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies

Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over age 65 in industrialized nations. Intravitreous injection of anti-VEGF (vascular endothelial growth factor) therapies, such as ranibizumab (trade name: Lucentis), provides an effective treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Leilei, Si, Ting, Fischer, Andrew J., Letson, Alan, Yuan, Shuai, Roberts, Cynthia J., Xu, Ronald X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537102/
https://www.ncbi.nlm.nih.gov/pubmed/26273831
http://dx.doi.org/10.1371/journal.pone.0135608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537102/
https://www.ncbi.nlm.nih.gov/pubmed/26273831
http://dx.doi.org/10.1371/journal.pone.0135608

Ejemplares similares